Shares of Genesis Healthcare Inc. (NYSE:GEN) have received an average recommendation of “Hold” from the six research firms that are covering the company. One investment analyst has rated the stock with a sell recommendation and five have assigned a hold recommendation to the company. The average 1 year target price among brokerages that have covered the stock in the last year is $2.89.

GEN has been the subject of a number of research analyst reports. Bank of America Corp. set a $1.80 price objective on shares of Genesis Healthcare and gave the company a “sell” rating in a report on Monday, September 19th. RBC Capital Markets lowered shares of Genesis Healthcare from an “outperform” rating to a “sector perform” rating and increased their price objective for the company from $3.00 to $3.50 in a report on Monday, November 21st. Finally, Royal Bank Of Canada lowered shares of Genesis Healthcare from an “outperform” rating to a “sector perform” rating and increased their price objective for the company from $3.00 to $3.50 in a report on Monday, November 21st.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Rhumbline Advisers increased its position in Genesis Healthcare by 84.5% in the third quarter. Rhumbline Advisers now owns 58,531 shares of the company’s stock worth $156,000 after buying an additional 26,800 shares in the last quarter. First Washington CORP purchased a new position in Genesis Healthcare during the third quarter worth approximately $2,860,000. Bank of New York Mellon Corp increased its position in Genesis Healthcare by 20.6% in the third quarter. Bank of New York Mellon Corp now owns 216,011 shares of the company’s stock worth $577,000 after buying an additional 36,940 shares in the last quarter. Phoenix Investment Adviser LLC increased its position in Genesis Healthcare by 93.2% in the third quarter. Phoenix Investment Adviser LLC now owns 186,610 shares of the company’s stock worth $498,000 after buying an additional 90,000 shares in the last quarter. Finally, Columbia Pacific Advisors LLC increased its position in Genesis Healthcare by 24.6% in the second quarter. Columbia Pacific Advisors LLC now owns 4,026,928 shares of the company’s stock worth $7,128,000 after buying an additional 795,272 shares in the last quarter. Hedge funds and other institutional investors own 8.73% of the company’s stock.

WARNING: “Brokerages Set Genesis Healthcare Inc. (GEN) Target Price at $2.89” was first posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this article on another site, it was illegally stolen and reposted in violation of US and international trademark & copyright law. The legal version of this article can be read at https://www.thecerbatgem.com/2016/11/26/brokerages-set-genesis-healthcare-inc-gen-target-price-at-2-89.html.

Genesis Healthcare (NYSE:GEN) opened at 3.62 on Monday. Genesis Healthcare has a 52 week low of $1.38 and a 52 week high of $5.13. The company has a 50 day moving average of $2.89 and a 200 day moving average of $2.32. The stock’s market capitalization is $327.54 million.

Genesis Healthcare (NYSE:GEN) last announced its quarterly earnings data on Thursday, November 3rd. The company reported ($0.23) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.40) by $0.17. The company had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.39 billion. During the same period last year, the business earned $0.07 earnings per share. The company’s quarterly revenue was up .2% compared to the same quarter last year. Equities analysts expect that Genesis Healthcare will post ($1.20) EPS for the current fiscal year.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, formerly Skilled Healthcare Group, Inc, is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services, including physician services and other healthcare related services.

5 Day Chart for NYSE:GEN

Receive News & Stock Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related stocks with our FREE daily email newsletter.